Dongwha Pharm.Co.,Ltd
Символ: 000020.KS
KSC
8750
KRWПазарна цена днес
8.7887
Съотношение P/E
0.0388
Коефициент PEG
242.53B
MRK Cap
- 0.02%
Доходност на DIV
Dongwha Pharm.Co.,Ltd (000020-KS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 403585.89 | 87234.2 | 107694.5 | 121509.6 | |||||||||||||||||
balance-sheet.row.short-term-investments | 102647.9 | 14917.1 | 73347.4 | 61030 | |||||||||||||||||
balance-sheet.row.net-receivables | 299433.48 | 74484.3 | 72638.2 | 62266.7 | |||||||||||||||||
balance-sheet.row.inventory | 229754.02 | 70697.2 | 46783.6 | 36244 | |||||||||||||||||
balance-sheet.row.other-current-assets | 6838.67 | 5284.4 | 411.1 | 178.3 | |||||||||||||||||
balance-sheet.row.total-current-assets | 939612.06 | 237700 | 227527.5 | 220198.6 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 668265.06 | 188330.5 | 151152.7 | 142850.5 | |||||||||||||||||
balance-sheet.row.goodwill | 34150.65 | 20483.3 | 4555.8 | 4555.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 69485.51 | 35994.5 | 11146.7 | 13582.4 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 103636.16 | 56477.8 | 15702.5 | 18138.2 | |||||||||||||||||
balance-sheet.row.long-term-investments | 183722.26 | 73880.1 | -16766.6 | -9737.1 | |||||||||||||||||
balance-sheet.row.tax-assets | 22283.83 | 6241.8 | 6400 | 6194.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 96350.11 | 2342.2 | 77120.4 | 70160 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 1074257.42 | 327272.4 | 233609 | 227605.8 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 2013869.48 | 564972.4 | 461136.5 | 447804.5 | |||||||||||||||||
balance-sheet.row.account-payables | 117847.48 | 31412.3 | 22231.8 | 17118.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 28107.34 | 20371.5 | 4619.7 | 6418.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 26394.25 | 2224.5 | 5443.8 | 7788.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 23026.18 | 16127.7 | 2044.3 | 5055.7 | |||||||||||||||||
Deferred Revenue Non Current | 22922.73 | 11756.1 | 22.9 | 40.5 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 12884.81 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 114043.02 | 52909.4 | 47508.8 | 5988.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 80283.59 | 51523 | 6900.9 | 21210 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 23932.14 | 11756.1 | 3686.8 | 3514.6 | |||||||||||||||||
balance-sheet.row.total-liab | 424273.28 | 157656.9 | 82463.2 | 87671.3 | |||||||||||||||||
balance-sheet.row.preferred-stock | 9685.15 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 111725.88 | 27931.5 | 27931.5 | 27931.5 | |||||||||||||||||
balance-sheet.row.retained-earnings | 1014003.98 | 34480.7 | 311972.2 | 290329 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1026701.46 | 293197.7 | 274806 | 261485.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -651565.63 | 16169.6 | -250309.3 | -232811.1 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1510550.85 | 371779.5 | 364400.4 | 346934.9 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1999367.38 | 564972.4 | 461136.5 | 447804.5 | |||||||||||||||||
balance-sheet.row.minority-interest | 79045.35 | 35536 | 14272.8 | 13198.3 | |||||||||||||||||
balance-sheet.row.total-equity | 1589596.2 | 407315.5 | 378673.3 | 360133.2 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1999367.38 | - | - | - | |||||||||||||||||
Total Investments | 286370.16 | 88797.1 | 56580.9 | 51292.9 | |||||||||||||||||
balance-sheet.row.total-debt | 62889.66 | 48255.4 | 6664 | 11474.1 | |||||||||||||||||
balance-sheet.row.net-debt | -238048.33 | -24061.8 | -27683.1 | -49005.5 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 28140.86 | 27438.3 | 21591.2 | 19582.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 13896.03 | 13896 | 12509.1 | 12093 | |||||||||||||||||
cash-flows.row.deferred-income-tax | -3833.93 | -41674.5 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 76.11 | 76.1 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -19296.66 | -19296.7 | -18086.3 | -4035.4 | |||||||||||||||||
cash-flows.row.account-receivables | -4300.66 | -4300.7 | -5636 | 750.8 | |||||||||||||||||
cash-flows.row.inventory | -12307.6 | -12307.6 | -14104.5 | -1443.4 | |||||||||||||||||
cash-flows.row.account-payables | 2801.9 | 2801.9 | 5014.1 | -1532.4 | |||||||||||||||||
cash-flows.row.other-working-capital | -5490.29 | -5490.3 | -3359.9 | -1810.4 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 10184.2 | 48727.4 | 13206.7 | 8390.8 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 29166.61 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -26345.58 | -26345.6 | -20091.5 | -24774.2 | |||||||||||||||||
cash-flows.row.acquisitions-net | -20519.44 | -18896.4 | 2599.2 | -2070.4 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -27918.35 | -27918.4 | -143537.9 | -105847.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 76140.54 | 76140.5 | 114969.9 | 104048.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | 1505.79 | -117.3 | 2788.3 | 3230 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 2862.95 | 2863 | -43272 | -25413.9 | |||||||||||||||||
cash-flows.row.debt-repayment | -21000 | -13500 | -7500 | -7800 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -4982.24 | -4982.2 | -4982.2 | -4969.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | 32566.43 | 24347.7 | 469.2 | 3986.5 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5865.5 | 5865.5 | -12013 | -8782.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 74.95 | 74.9 | -68.2 | 48.8 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 37970.01 | 37970 | -26132.5 | 1883.2 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 300937.99 | 72317.1 | 34347.1 | 60479.6 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 262967.98 | 34347.1 | 60479.6 | 58596.4 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 29166.61 | 29166.6 | 29220.8 | 36031.2 | |||||||||||||||||
cash-flows.row.capital-expenditure | -26345.58 | -26345.6 | -20091.5 | -24774.2 | |||||||||||||||||
cash-flows.row.free-cash-flow | 2821.03 | 2821 | 9129.3 | 11257 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 361108.56 | 361108.6 | 340426.3 | 293018.1 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 172233.97 | 176983.8 | 159436.1 | 143671.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 188874.6 | 184124.7 | 180990.3 | 149347 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 14309.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 126234.64 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 77077.52 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -254321.34 | -342332.7 | 55166.4 | 53095.9 | |||||||||||||||||
income-statement-row.row.operating-expenses | 43202.32 | 342332.7 | 151075.2 | 126848.5 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 218846.58 | 342332.7 | 310511.2 | 270519.6 | |||||||||||||||||
income-statement-row.row.interest-income | 3252.82 | 3252.8 | 2387.7 | 1067.9 | |||||||||||||||||
income-statement-row.row.interest-expense | -4136.53 | 308 | 370 | 383.1 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 77077.52 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 18179.7 | 18179.7 | -6829.5 | 4030.9 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -254321.34 | -342332.7 | 55166.4 | 53095.9 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 18179.7 | 18179.7 | -6829.5 | 4030.9 | |||||||||||||||||
income-statement-row.row.interest-expense | -4136.53 | 308 | 370 | 383.1 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 127044.31 | 13896 | 13981 | 14940.8 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 142261.99 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 18775.88 | 18775.9 | 29915.1 | 22496.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | 36955.58 | 36955.6 | 23085.5 | 26527.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 8718.53 | 8718.5 | 1494.3 | 6944.5 | |||||||||||||||||
income-statement-row.row.net-income | 27438.29 | 27438.3 | 20383.5 | 17870.4 |
Често задавани въпроси
Какво е Dongwha Pharm.Co.,Ltd (000020.KS) общи активи?
Dongwha Pharm.Co.,Ltd (000020.KS) общите активи са 564972408621.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 171698391954.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 101.776.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 101.776.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.076.
Какъв е общият приход на предприятието?
Общият приход е 0.052.
Каква е Dongwha Pharm.Co.,Ltd (000020.KS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 27438289760.000.
Какъв е общият дълг на фирмата?
Общият дълг е 48255358875.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 342332682000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 72317114790.000.